Data from four major pivotal trials will be shared, but AstraZeneca medications and pipeline molecules appear in more than 90 abstracts for the upcoming conference in Berlin.

This issue showcases strategies that organizations are adopting to stay competitive as pressing industry trends shape the ...

US President Donald Trump was due to make an announcement that a source said would confirm AstraZeneca as the second of 17 major pharmaceutical companies, after Pfizer, to agree to most-favored-nation ...

Pharma accelerates specialized R&D and clinical pipelines via agentic AI and collaboration, while manufacturing scales through CGT 2.0 flexibility, automation, and digitized supply chain security.

AstraZeneca’s $4.5 billion investment in Virginia expands its US drug manufacturing footprint, creating 3600 jobs and ...

The new label for prefilled syringes, in conjunction with innovations from SCHOTT Pharma, enables integrated tamper-evidence ...

At the Cell and Gene Meeting on the Mesa, a panel discussion was held on advanced therapy production and how it demands ...

The awarded $1.7 million in funding will support the company’s preclinical and clinical progress on DMX-1001 (noribogaine), ...

The growing demand for liquid medicines is increasingly driven by the unique needs of several distinct patient groups, improving compliance in these demographics through flexible, palatable dosing ...

The licensing of Talicia, an FDA-approved fixed-dose therapy, to key at-risk markets strategically combats an increasingly ...

Radiopharmaceuticals provide targeted cancer treatment, minimizing side effects and offering a theranostic approach for precise diagnosis and therapy. Challenges include global demand, isotope supply, ...